Health Outcomes in Rheumatoid Arthritis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2006 by Johns Hopkins University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00346411
First received: June 28, 2006
Last updated: NA
Last verified: May 2006
History: No changes posted

June 28, 2006
June 28, 2006
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Health Outcomes in Rheumatoid Arthritis
Health Outcomes in Rheumatoid Arthritis

This research is being done to help us learn about how different factors related to treatment affect rheumatoid arthritis (RA). This is not a treatment study. We will follow the patient for one year as he or she receives usual treatment from his or her rheumatologist. Up to 360 adults with RA may join this study.

Not Provided
Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
Rheumatoid Arthritis
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
260
Not Provided
Not Provided

Inclusion Criteria:

  • Males and females age 19 or older
  • Current active, adult-onset rheumatoid arthritis who meet ACR criteria for RA and have: (American College of Rheumatology [ACR] functional class I–III), defined as:
  • 3 or more swollen or tender joints and
  • Morning stiffness of 45min or longer
  • OR judged by their rheumatologist to have active disease
  • No evidence of other inflammatory diseases (e.g., Crohn’s, IBS)
  • Functional class I, II or III

Exclusion Criteria:

  • Individuals with significant cardiovascular disease (CHF, stroke, MI)
  • Unwilling to have medications monitored and/or comply with protocol
  • Not fluent in English
  • Planning to move from area within next year or change health insurance (which would preclude ongoing care by JH rheumatologist)
  • Enrolled in study evaluating efficacy of new or existing RA medications
Both
19 Years and older
No
Contact: Steffany Haaz, MFA (410) 550-5216 shaaz1@jhmi.edu
Contact: Susan Bartlett, PhD (410) 550-7775 bartlett@jhmi.edu
United States
 
NCT00346411
NA_00001359
Not Provided
Not Provided
Johns Hopkins University
Not Provided
Principal Investigator: Susan Bartlett, PhD Johns Hopkins School of Medicine
Study Director: Steffany Haaz, MFA Johns Hopkins University
Johns Hopkins University
May 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP